Univar Czech s.r.o. acquires enzymes distribution business of Ekozym

28-Feb-2007

Univar N.V. announced that its subsidiary Univar Czech s.r.o. in Prague has acquired the enzymes distribution business of Ekozym s.r.o., based in Vizovice, Czech Republic. This highly specialized business is based on the distribution of products from Novozymes A/S.

According to the company, this is another step towards Univar's ambitions to be a key player in Central and Eastern Europe. It will further expand Univar's activities serving the detergent, brewing, beverage alcohol and food markets in the Czech Republic, as well as strengthen the relationship with Novozymes.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms - 'South-South' biotech collaborations boost health, economies: Study

Nanostructures in human teeth

Nanostructures in human teeth

Additional Data from Multiple Phase 1 and 2 Studies of S*BIO’s Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis - SB1518 Alleviates MF-Associated Splenomegaly and Shows No Myelosuppression and No Exacerbation of Cytopenias

Signs of dementia are written in the blood - 33 metabolic compounds linked to dementia could be key to new methods of diagnosis and treatment

Signs of dementia are written in the blood - 33 metabolic compounds linked to dementia could be key to new methods of diagnosis and treatment

Blood brain barrier gateway found

European Commision approves Amgen´s KINERET® for the treatment of rheumatoid arthritis - First Interleukin-1 receptor antagonist represents new way to treat RA

Evotec Enters into Long-Term Focused Library Agreement with Almirall - Value Exceeding EUR 2.5 m over the Two-Year Contract Period

Why gold nanoparticles can penetrate cell walls - Gold nanoparticles with special coatings can deliver drugs or biosensors to a cell's interior without damaging it

BAC signs license agreement with Hematech

University spinout receives £1.2 million to tackle antimicrobial resistance

University spinout receives £1.2 million to tackle antimicrobial resistance

Procoralan (ivabradine) is Shown to Reduce Myocardial Infarction and Revascularisation in Stable Coronary Patients

Salmonella widespread in pig breeding farms